The Food and Drug Administration has issued an urgent warning to consumers, healthcare providers, and pharmacies after discovering counterfeit Ozempic (semaglutide) injection 1 mg in the legitimate U.S. drug supply chain. The agency has seized thousands of units of the counterfeit product as part of an ongoing investigation into how these fake medications infiltrated authorized distribution channels.
The FDA is advising wholesalers, retail pharmacies, healthcare practitioners, and patients to carefully verify the authenticity of Ozempic products before use. The presence of counterfeit medications in the legitimate supply chain—rather than through illicit online marketplaces—represents a particularly serious safety concern, as these products typically pass through trusted distributors and pharmacies where consumers expect to receive authentic medications.
The warning comes amid unprecedented demand for semaglutide products, driven by their effectiveness for both type 2 diabetes management and weight loss. This surge in demand has created persistent shortages and backorder situations, conditions that historically provide opportunities for counterfeiters to exploit desperate patients seeking these medications. Counterfeit drugs pose serious health risks, as they may contain incorrect doses of active ingredients, harmful substances, or no medication at all.
Healthcare providers and pharmacies should examine Ozempic packaging and products for signs of tampering or irregularities, including unusual labeling, packaging defects, or inconsistencies with authentic product appearance. The FDA has not yet disclosed specific details about how to identify the counterfeit products or which distribution channels were affected by the infiltration.
Patients who have purchased Ozempic should verify their medication was obtained through a licensed pharmacy and report any concerns about product authenticity to the FDA’s MedWatch program. Those experiencing unexpected side effects or lack of therapeutic effect should contact their healthcare provider immediately. The incident underscores the importance of obtaining prescription medications only through legitimate, licensed sources and avoiding online pharmacies or vendors that may operate outside regulatory oversight.
